Your shopping cart is currently empty

MorHap is a hapten derived from heroin. When conjugated with tetanus toxoid (TT), palm-CV2, and liposomes containing monophosphoryl lipid A (MPLA), it can partially block heroin-induced analgesia and hyperlocomotion in mice. Additionally, MorHap-based conjugates significantly inhibit the binding of HIV-1 to the α4β7 receptor. It is utilized in the research and development of vaccines related to heroin addiction and HIV-1 infection.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | MorHap is a hapten derived from heroin. When conjugated with tetanus toxoid (TT), palm-CV2, and liposomes containing monophosphoryl lipid A (MPLA), it can partially block heroin-induced analgesia and hyperlocomotion in mice. Additionally, MorHap-based conjugates significantly inhibit the binding of HIV-1 to the α4β7 receptor. It is utilized in the research and development of vaccines related to heroin addiction and HIV-1 infection. |
| Formula | C39H38N2O3S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.